Skip to Main Content

Paper Details

The effects of single- and multiple-dose administration of bococizumab (RN316/PF-04950615), a humanized IgG2οa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studies.
Cardiovasc Ther
14
2018
Author NameAffiliation
Hong LiangPfizer Inc.
Jaume PonsPfizer Inc.
  • 1 - 2

Datasets

Release 1.2